Novo Nordisk Takes On Hims Over Copycat GLP-1 Pill
When telehealth company Hims & Hers said last week it planned to sell a GLP-1 pill dupe for the low price of $49, it caught a lot of people — including...To view the full article, register now.
Already a subscriber? Click here to view full article